Kristin Abate

KPTI

Kristin Abate serves as officer: Chief Accounting Officer at Karyopharm Therapeutics Inc. (KPTI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$9.0K

Net Position

Net Seller

$9.0K

Companies Traded

KPTI

Active Period

Mar 2025 – Jan 2026

7 total trades

Most Recent

Sell KPTI

Jan 29, 2026 · $351.50

Kristin Abate's Insider Trading at Karyopharm Therapeutics Inc. (KPTI)

Buys

0 · $0.00

Sells

7 · $9.0K

Total Shares Bought

Total Shares Sold

1,521

KPTI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 29, 2026	Sell	50	$7.03	$351.50	22,622
Jan 22, 2026	Sell	265	$5.96	$1.6K	22,580
Oct 3, 2025	Sell	362	$6.30	$2.3K	10,046
Sep 16, 2025	Sell	23	$6.43	$147.89	10,408
Sep 4, 2025	Sell	12	$6.78	$81.36	9,463
Jul 23, 2025	Sell	238	$4.00	$952.00	9,475
Mar 6, 2025	Sell	571	$6.29	$3.6K	9,713